| GA23215-50mg |
|
282726-24-3 |
N-((RS)-2-Hydroxy-propyl)-Val-Leu-anilide
|
0 |
C20H33N3O3 |
|
|
|
| GA23214-250mg |
|
283159-27-3 |
N-((RS)-2-Hydroxy-1-phenyl-ethyl)-Val-Leu-anilide
|
0 |
C25H35N3O3 |
|
|
|
| GA23214-50mg |
|
283159-27-3 |
N-((RS)-2-Hydroxy-1-phenyl-ethyl)-Val-Leu-anilide
|
0 |
C25H35N3O3 |
|
|
|
| GA23213-5mg |
|
147217-25-2 |
Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH
|
0 |
C60H105N17O12 |
|
|
|
| GA23213-1mg |
|
147217-25-2 |
Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH
|
0 |
C60H105N17O12 |
|
|
|
| GA23212-25mg |
|
125678-68-4 |
Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
0 |
C42H82N12O8 |
|
|
|
| GA23212-5mg |
|
125678-68-4 |
Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
0 |
C42H82N12O8 |
|
|
|
| GA23211-250mg |
|
14246-55-0 |
|
0 |
C16H31NO3 |
|
|
|
| GA23211-50mg |
|
14246-55-0 |
|
0 |
C16H31NO3 |
|
|
|
| GA23210-1mg |
|
— |
Myristoyl-(Lys¹²·²⁷·²⁸)-VIP-Gly-Gly-Thr (free acid)
|
0 |
C171H283N45O47S |
|
|
|
| GA23210-005mg |
|
— |
Myristoyl-(Lys¹²·²⁷·²⁸)-VIP-Gly-Gly-Thr (free acid)
|
0 |
C171H283N45O47S |
|
|
|
| GA23209-1mg |
|
313642-00-1 |
Myosin Light Chain Kinase (480-501)
|
0 |
C120H209N41O28S2 |
|
|
|
| GA23209-005mg |
|
313642-00-1 |
Myosin Light Chain Kinase (480-501)
|
0 |
C120H209N41O28S2 |
|
|
|
| GA23208-1mg |
|
2022956-48-3 |
Myelin Oligodendrocyte Glycoprotein (35-55) amide (rat, mouse)
|
0 |
C118H178N36O28S |
|
|
|
| GA23208-005mg |
|
2022956-48-3 |
Myelin Oligodendrocyte Glycoprotein (35-55) amide (rat, mouse)
|
0 |
C118H178N36O28S |
|
|
|
| GA23207-1mg |
|
163158-19-8 |
Myelin Oligodendrocyte Glycoprotein (35-55) (human)
|
0 |
C120H179N35O28S |
|
|
|
| GA23207-005mg |
|
163158-19-8 |
Myelin Oligodendrocyte Glycoprotein (35-55) (human)
|
0 |
C120H179N35O28S |
|
|
|
| GA23206-5mg |
|
444305-16-2 |
Myelin Basic Protein (85-99) Peptide Antagonist
|
0 |
C70H114N18O21 |
|
|
|
| GA23206-1mg |
|
444305-16-2 |
Myelin Basic Protein (85-99) Peptide Antagonist
|
0 |
C70H114N18O21 |
|
|
|
| GA23205-5mg |
|
178823-45-5 |
Myelin Basic Protein (83-99) (bovine)
|
0 |
C93H143N25O24 |
|
|
|
